Your browser doesn't support javascript.
loading
Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression.
Dogan, Izzet; Aydin, Esra; Khanmammadov, Nijat; Paksoy, Nail; Saip, Pinar; Aydiner, Adnan.
Afiliación
  • Dogan I; Department of Medical Oncology, Istanbul University Institute of Oncology, Millet Street/Fatih, Istanbul, 34093, Turkey. dr.izzetdogan@gmail.com.
  • Aydin E; Department of Medical Oncology, Istanbul University Institute of Oncology, Millet Street/Fatih, Istanbul, 34093, Turkey.
  • Khanmammadov N; Department of Medical Oncology, Istanbul University Institute of Oncology, Millet Street/Fatih, Istanbul, 34093, Turkey.
  • Paksoy N; Department of Medical Oncology, Istanbul University Institute of Oncology, Millet Street/Fatih, Istanbul, 34093, Turkey.
  • Saip P; Department of Medical Oncology, Istanbul University Institute of Oncology, Millet Street/Fatih, Istanbul, 34093, Turkey.
  • Aydiner A; Department of Medical Oncology, Istanbul University Institute of Oncology, Millet Street/Fatih, Istanbul, 34093, Turkey.
Sci Rep ; 13(1): 8779, 2023 05 31.
Article en En | MEDLINE | ID: mdl-37258548
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Reino Unido